Valitor
Valitor is initially focused on improving patient outcomes in ophthalmology and vision-threatening diseases by conquering long-standing limitations of traditional biologic medicines.
$28M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 10, 2012 (14 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $28M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Valitor
GGlycoEra$130M Series B+ · May 2025
SSeen Health$22M Series A · Nov 2024
CCordance Medical$8M Seed · Nov 2025
MMindRhythmSeed · Nov 2021
IInnornaSeries B+ · Apr 2022EEyebot$20M Series A · Aug 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/valitor (get a free API key).